31.58
-0.09
(-0.28%)
After Hours: 31.57
-0.01
(-0.02%)
Jun 19, 4:43PM EDT
NASDAQ
real-time data -
Disclaimer
Currency in USD
| Range | 31.51 - 31.92 |
| 52 week | 29.91 - 39.86 |
| Open | 31.79 |
| Vol / Avg. | 563,975.00/671,025.00 |
| Mkt cap | 1.81B |
| P/E | 38.51 |
| Div/yield | - |
| EPS | 0.82 |
| Shares | 57.33M |
| Beta | 0.74 |
| Inst. own | 95% |
Events
Jul 29, 2013
Q2 2013 Thoratec Corporation Earnings Release
Jun 19, 2013
Thoratec Corporation at Wells Fargo Health Care Conference
Jun 13, 2013
Thoratec Corporation at Goldman Sachs Healthcare Conference
May 22, 2013
Thoratec Corporation Annual Shareholder Meeting
May 16, 2013
Thoratec Corporation at Bank of America Merrill Lynch Health Care Conference
May 2, 2013
Q1 2013 Thoratec Corporation Earnings Conference Call -
Apr 29, 2013
Q1 2013 Thoratec Corporation Earnings Release
|
More events from DailyFinance »
|
Key stats and ratios
| Q1 (Mar '13) | 2012 | |
| Net profit margin | 15.43% | 11.42% |
| Operating margin | 19.87% | 15.39% |
| EBITD margin | - | 19.40% |
| Return on average assets | 10.36% | 8.14% |
| Return on average equity | 12.01% | 9.51% |
| Employees | 855 | - |
| Carbon Disclosure Rating | - | - |
Address
6035 Stoneridge Drive
Pleasanton, CA 94588
United States - Map
+1-925-8478600 (Phone)
+1-925-8478574 (Fax)
Pleasanton, CA 94588
United States - Map
+1-925-8478600 (Phone)
+1-925-8478574 (Fax)
Website links
External links
Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Research Reports - Reuters
Discussion Group - Google Finance
Volume delayed by 15 mins.
Advertisement
Description
Thoratec Corporation is engaged in mechanical circulatory support with a product portfolio to treat the range of clinical needs for advanced heart failure (HF) patients. The Company develops, manufactures and markets medical devices used for circulatory support. For advanced HF, its primary product lines are its ventricular assist devices (VADs), which include the Thoratec Paracorporeal Ventricular Assist Device (PVAD), the Thoratec Implantable Ventricular Assist Device (IVAD), the HeartMate Left Ventricular Assist System (HeartMate XVE), and the HeartMate II Left Ventricular Assist System (HeartMate II). For acute HF, its product lines are the CentriMag Acute Circulatory System (CentriMag) and for pediatric patients the PediMag/PediVAS Acute Circulatory System (PediMag/PediVAS). On August 3, 2011, the Company acquired Levitronix LLC (Levitronix). During the year ended December 31, 2011, the Company discontinued the sale of the HeartMate XVE.
Officers and directors
| Neil F. Dimick CPA | Independent Chairman of the Board | |
| Gerhard F. Burbach | President, Chief Executive Officer, Director | |
| Taylor C. Harris | Chief Financial Officer, Vice President | |
| David A. Lehman | Senior Vice President, General Counsel, Secretary | |
| J. Daniel Cole | Independent Director | |
| Steven H. Collis | Independent Director | |
| D. Keith Grossman | Independent Director | |
| William A. Hawkins III | Independent Director | |
| Paul A. LaViolette | Independent Director |